Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.
| Name | Percentage | |
|---|---|---|
| Thryve | 100% | |
| uBiome | 100% | |
| FASTQ processed thru both Thryve and BiomeSight | 100% | |
| Tiny | 88.9% | |
| BiomeSightRdp | 88.9% | |
| CerbaLab | 88.9% | |
| CosmosId | 88.9% | |
| es-xenogene | 88.9% | |
| Precision | 77.8% | |
| SequentiaBiotech | 77.8% | |
| Thorne | 77.8% | |
| AmericanGut | 77.8% | |
| BiomeSight | 77.8% | |
| Medivere | 66.7% | |
| Microba | 66.7% | |
| vitract | 66.7% | |
| bugspeak | 55.6% | |
| Gut Zoomer (vibrant-wellness) | 55.6% | |
| Laboratorio Teletest | 44.4% | |
| GI360 Stool (UK) | 44.4% | |
| Microba1 | 44.4% | |
| Metagenomics Stool (De Meirleir) (16s Limited) | 33.3% | |
| GutScan | 33.3% | |
| MyBiota (Austria) | 22.2% | |
| Medivere Mikrobiom Plus Stuhlanalyse | 22.2% | |
| Genova Gi Effects (cfu/g) | 22.2% | |
| DayTwo | 22.2% | |
| Diagnostic Solution GI-Map (cfu/gm) | 22.2% | |
| GanzImmun Diagnostic A6 (cfu/gm) | 22.2% | |
| GanzimmunDiag | 22.2% | |
| Smart Gut (16s - Limited Taxonomy) | 22.2% | |
| SynLab (EU) | 22.2% | |
| TinyHealth | 11.1% | |
| Viome (Latest Reports Fail to provide ANY measurements) | 11.1% | |
| GanzImmun Diagnostics AG Befundbericht | 11.1% | |
| Biomefx | 11.1% | |
| Chuckling Goat | 11.1% | |
| Medivere: Darm Mikrobiom Stuhltest (16s limited) | 11.1% | |
| Nordic Laboratories | 11.1% | |
| NutriPATH | 11.1% |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
